Kwality Pharmaceuticals Limited (KPL) Price Target & Share Price Forecast
Not a guess. A distribution.
As of , the Kwality Pharmaceuticals Limited (KPL) 1-year price target is ₹15,544 - +477.8% from the current price of ₹2,690. The 80% confidence range is ₹7,733-₹30,955, with a 99.9% probability of finishing above today's price.
Probability-weighted price target and forecast for Kwality Pharmaceuticals Limited (KPL) across 2027, 2029, and 2031. Built from a 10,000-trial Monte Carlo simulation on 0.3 years of NSE historical data - so you see the full range of where the price could realistically land, weighted by likelihood. No analyst opinions. Just statistics.
KPL price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds KPL hits common targets within the simulated horizon?
How the KPL price target & forecast are calculated
We ran 10,000 simulated price paths for Kwality Pharmaceuticals Limited (KPL) using Geometric Brownian Motion (GBM) - the same probability framework used in institutional risk-management systems. The simulation uses KPL's actual 0.3-year historical volatility (53.4%) and mean log return (189.5%/year), so it reflects real market behaviour, not assumptions.
Each of the 10,000 trials projects a unique KPL share price path day-by-day for 5 years. The percentile bands (P10/P50/P90) show the full distribution of outcomes - your real price target range, not a single guess.
Why this KPL forecast differs from analyst price targets: Analyst targets are point estimates from subjective valuation models. Monte Carlo price-target forecasts are probability distributions from actual market data. They tell you the range and likelihood of where KPL could realistically land - so you can plan for the spread of outcomes, not bet on a wish.
KPL price target & forecast - probability table
| Horizon | Pessimistic (P10) | Median (P50) | Optimistic (P90) | P(↑ from today) | P(2× return) |
|---|---|---|---|---|---|
| 1 year (2027) | ₹7,733 | ₹15,544 | ₹30,955 | 99.9% | 97.5% |
| 3 years (2029) | ₹1,56,392 | ₹5,18,506 | ₹16,89,087 | 100.0% | 100.0% |
| 5 years (2031) | ₹37,57,909 | ₹1,77,82,888 | ₹8,18,07,847 | 100.0% | 100.0% |
Generated 22/7/2026, 9:59:00 am. Refreshed every 6 hours from 0.3y of NSE history.
KPL price target & forecast - FAQs
What is the Kwality Pharmaceuticals Limited (KPL) price target / share price forecast for 2031?
Based on a 10,000-trial Monte Carlo simulation using historical volatility, KPL's 5-year median (P50) forecast is ₹1,77,82,888. The 80% confidence band is ₹37,57,909-₹8,18,07,847. The probability of the price being above today's ₹2,690 in 5 years is 100.0%.
How is Monte Carlo different from analyst price targets?
Analyst targets are point estimates based on subjective valuation models. Monte Carlo simulations produce a probability distribution from actual historical volatility - showing the full range of where the price could realistically land, weighted by likelihood. No opinions, just statistics.
Can KPL double in 5 years?
The probability of KPL reaching 2× the current price (₹5,380) within 5 years is 100.0%, based on this simulation.
Is this prediction accurate?
No simulation can predict the future - but Monte Carlo gives you a calibrated range of outcomes weighted by historical probability. It accounts for volatility better than any single price target. Use it as a decision-support tool, not a guarantee.
How often is this forecast updated?
Every 6 hours, based on the latest NSE close prices and 0.3 years of historical data.
For information and education only. These figures are a statistical Monte Carlo forecast (a probability distribution from KPL's own historical volatility), shown with the method above. They are not a price-target "call", a prediction, or advice. Downstox is not a SEBI-registered Research Analyst or Investment Adviser, and nothing here is a recommendation to buy or sell KPL. Markets carry risk; consult a SEBI-registered adviser before investing.